Middle East and Africa Intravenous Solutions Market Report and Forecast 2024-2032

Middle East and Africa Intravenous Solutions Market Outlook

The Middle East and Africa intravenous solutions market is expected to grow at a CAGR of 6.7% in the forecast period of 2024-2032.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Key Trends in the Market 

Intravenous solutions or intravenous fluids are described as supplemental fluids employed in intravenous therapy. They are used to maintain or restore the normal volume of fluids in a person along with balancing electrolytes when there is no possibility for an oral route. The therapy is an effective and efficient method of providing fluids promptly while controlling electrolyte losses, as well as in managing treatments along with blood products.

• With an increase in natality rates, rising geriatric population, and surging prevalence of cancer, the intravenous solutions market in the Middle East and Africa region is expected to gain momentum in the coming years.

• An increase in the prevalence of malnutrition along with growing healthcare expenditure is further expected to boost the market growth of intravenous solutions over the upcoming years.

• The higher efficacy and faster response time related to IV solution therapy are promoting the growth of the Middle East and Africa intravenous solutions market.

• Market Opportunities and Challenges 

• The surging investments by health agencies of various countries in the healthcare industry are expected to create market opportunities during the forecast period.

• Going further, the surging participation of individuals in physical activities is further expected to push forward the adoption of intravenous solutions for faster recoveries.

• The possible side effects of IV medication which can be both mild and dangerous like allergic reactions are likely to hamper the demand in the Middle East and Africa intravenous solutions market.

Market Analysis 

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Based on type, the market can be segmented into partial parenteral nutrition and total parenteral nutrition. Based on nutrients, the market can be divided into carbohydrates, salts and electrolytes, minerals, vitamins, and amino acids. On the basis of countries, the market can be divided into Saudi Arabia, the United Arab Emirates, Kuwait, Algeria, Nigeria, Kenya, Morocco, and South Africa, among others.

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the Middle East and Africa Intravenous Solutions market, covering their competitive landscape and latest developments like mergers, acquisitions, investments and expansion plans.

• Becton, Dickinson and Company

• Fresenius Kabi South Africa (Pty) Ltd

• Well Pharma Medical Solutions LLC

• Alpha Medical Manufacturers Limited

• Intravenous Infusions Plc

• Others

Market Share by Type

The total parenteral nutrition segment is expected to hold significant growth in the intravenous solutions market share during the forecast period on account of the increase in gastrointestinal diseases, like Crohn’s Disease and Ulcerative Colitis. In such conditions, patients are not able to absorb or retain crucial nutrients, and thereby, such crucial nutrients are delivered via an intravenous route. With an increase in the geriatric population, the demand for the segment is growing during the forecast period across the market as the patients require crucial nutrients through intravenous routes.

Market Share by Nutrient

The amino acid segment is expected to gain momentum in the Middle East and Africa intravenous solutions market share on account of the rise in the number of cancer patients. Going further, the increasing adoption of unhealthy lifestyles along with evolving technology is further expected to influence the segment growth in the market over the upcoming years.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Competitive Landscape 

• Becton, Dickinson, and Company is a world leading medical technology enterprise involved in the development, manufacture, and sale of a variety of medical devices, diagnostic products, laboratory equipment, and supplies. It operates with three primary business segments which are BD Life Sciences, BD Interventional, and BD Medical.

• Fresenius Kabi South Africa (Pty) Ltd is a leading healthcare company. The company specialises in lifesaving technologies and medicines for transfusion, clinical nutrition, and infusion. Its services and products are used for chronically and critically ill patients.

• Well Pharma Medical Solutions LLC is the United Arab Emirates' first and only IV solutions producing plant catering to the ever-growing demand for life-saving IV solutions in DEHP-free containers and bags.

Other market players include Alpha Medical Manufacturers Limited and Intravenous Infusions Plc, among others. 

Key Highlights of the Report